Agreement of prolactin response to cimetidine and nomifensine in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia

Mauro Iodice, Gaetano Lombardi, Antonio Tommaselli, Riccardo Rossi, Lucio Annunziato, Marco Minozzi

Research output: Contribution to journalArticle

Abstract

The effect of acute injection of cimetidine, a selective histamine-2 receptor blocker, on prolactin (PRL) secretion was investigated in subjects with physiological puerperal hyperprolactinemia and pathological hyperprolactinemia. Failure of cimetidine to affect basal PRL levels was observed in all the subjects not responding to nomifensine, an antidepressant drug which enhances dopaminergic neurotransmission by inhibiting dopamine reuptake in the central dopamine synapses. In the subjects with puerperal and idiopathic hyperprolactinemia who responded to nomifensine test, cimetidine stimulated PRL secretion. These results indicate that cimetidine can be useful in the differential diagnosis between hyperprolactinemia states due to pituitary tumor or nontumor.

Original languageEnglish
Pages (from-to)333-335
Number of pages3
JournalNeuroendocrinology
Volume35
Issue number5
DOIs
Publication statusPublished - 1982

Keywords

  • Cimetidine
  • Hyperprolactinemia
  • Nomifensine

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Cellular and Molecular Neuroscience
  • Endocrine and Autonomic Systems
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Agreement of prolactin response to cimetidine and nomifensine in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia'. Together they form a unique fingerprint.

  • Cite this